Thal, D. R., Poesen, K., Vandenberghe, R. & De Meyer, S. Alzheimer’s disease neuropathology and its estimation with fluid and imaging biomarkers. Mol. Neurodegener. 20, 33 (2025).
Hansson, O. et al. The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimers Dement. 18, 2669–2686 (2022).
Therriault, J. et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat. Rev. Neurol. 20, 232–244 (2024).
Cummings, J. L. et al. Alzheimer’s disease drug development pipeline: 2025. Alzheimers Dement. 11, e70098 (2025).
Beach, T. G., Monsell, S. E., Phillips, L. E. & Kukull, W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J. Neuropathol. Exp. Neurol. 71, 266–273 (2012).
Cohen, A. D. & Villemagne, V. L. A brief history of Aβ imaging. Alzheimers Dement. 21, e70291 (2025).
Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925–937 (2003).
Rajani, R. M. et al. Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease. PLoS Biol. 22, e3002727 (2024).
Avila, J., Dominguez, J. & Diaz-Nido, J. Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development. Int. J. Dev. Biol. 38, 13–25 (1994).
Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B. A. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879–888 (1995).
... continue reading